What is the immediate management for a 35-year-old man brought by ambulance with altered mental status, minimally responsive to pain, Kussmaul respirations, fruity (sweet) odor to his breath, and yellow‑green fluid noted on exam, suggestive of diabetic ketoacidosis?

Immediate Management of Diabetic Ketoacidosis (DKA)

This patient requires immediate intravenous fluid resuscitation followed by continuous intravenous insulin infusion—this is a life-threatening diabetic ketoacidosis emergency that demands aggressive treatment to prevent mortality from severe dehydration, acidosis, and potential cerebral edema.

Initial Assessment and Stabilization

Upon arrival, immediately obtain:

• Blood glucose, venous blood gases, complete metabolic panel (electrolytes, BUN, creatinine)
• Serum ketones (β-hydroxybutyrate preferred over urine ketones)
• Complete blood count, urinalysis
• ECG to assess for cardiac complications and potassium abnormalities 1

The clinical presentation—altered mental status, minimal responsiveness, Kussmaul respirations (deep, rapid breathing compensating for metabolic acidosis), and fruity breath odor (acetone)—confirms severe DKA. The yellow-green fluid likely represents vomitus, which occurs in up to 25% of DKA cases 1.

Critical First Steps: Fluid Resuscitation

Begin aggressive fluid replacement BEFORE insulin therapy:

1. Initial fluid bolus: Administer 1-1.5 L of 0.9% normal saline over the first hour 1
2. Subsequent fluid management: Continue 0.9% normal saline at 250-500 mL/hour, adjusting based on hydration status, corrected serum sodium, and urine output 1
3. Corrected sodium calculation: Add 1.6 mEq/L to measured sodium for every 100 mg/dL glucose above normal to guide fluid choice 1

Insulin Therapy Protocol

Critical safety check: Do NOT start insulin if serum potassium is <3.3 mEq/L—this can cause fatal cardiac arrhythmias. If hypokalemia exists, replace potassium first 1.

For adults with moderate-to-severe DKA:

• Give 0.15 units/kg IV bolus of regular insulin
• Follow immediately with continuous IV infusion at 0.1 units/kg/hour (approximately 5-7 units/hour for average adult) 1
• Target glucose decline of 50-75 mg/dL per hour 1

If glucose doesn't fall by 50 mg/dL in the first hour:

• Verify adequate hydration status
• Double the insulin infusion rate hourly until achieving steady 50-75 mg/dL/hour decline 1

Glucose Management During Treatment

When blood glucose reaches 200-250 mg/dL:

• Add 5% or 10% dextrose to IV fluids
• Continue insulin infusion—do NOT stop insulin even when glucose normalizes
• The goal is to clear ketones, which takes longer than correcting hyperglycemia 1

Potassium Replacement (Critical)

Potassium shifts are dangerous in DKA:

• If K+ <3.3 mEq/L: Hold insulin, give potassium aggressively
• If K+ 3.3-5.2 mEq/L: Add 20-30 mEq potassium to each liter of IV fluid
• Use 2/3 potassium chloride and 1/3 potassium phosphate 1
• Monitor potassium every 2-4 hours

Bicarbonate Therapy

Generally NOT recommended unless pH <6.9, as studies show no benefit in resolution time or outcomes 1. If pH is 6.9-7.0, bicarbonate may be considered but is not necessary if pH ≥7.0 1.

Monitoring Requirements

Every 2-4 hours, check:

• Serum electrolytes (sodium, potassium, chloride)
• Blood glucose
• Venous pH (arterial blood gases usually unnecessary after initial assessment)
• Anion gap to monitor acidosis resolution 1

Monitor for cerebral edema (the leading cause of DKA mortality), especially if:

• Mental status deteriorates during treatment
• Headache, vomiting, or bradycardia develop
• This is more common in younger patients but can occur in adults 1

Resolution Criteria

DKA is resolved when ALL of the following are met:

• Blood glucose <200 mg/dL
• Serum bicarbonate ≥18 mEq/L
• Venous pH >7.3
• Anion gap normalized 1

Transition to Subcutaneous Insulin

Critical timing to prevent rebound ketoacidosis:

• Give subcutaneous basal insulin 2-4 hours BEFORE stopping IV insulin
• Overlap is essential—abrupt discontinuation causes recurrent DKA 1, 2
• Calculate total daily subcutaneous dose from the average hourly IV insulin rate over the last 12 hours before transition 3

Common Pitfalls to Avoid

1. Starting insulin before adequate fluid resuscitation—worsens hypotension
2. Stopping insulin when glucose normalizes—ketones take longer to clear; continue insulin and add dextrose instead 1
3. Ignoring potassium levels—both hypokalemia and hyperkalemia are life-threatening
4. Abrupt transition from IV to subcutaneous insulin—causes rebound hyperglycemia and ketoacidosis 1, 2
5. Over-aggressive fluid administration—increases cerebral edema risk, especially in younger patients 1

Identify and Treat Precipitating Cause

While managing DKA, search for triggers:

• Infection (most common—obtain cultures, chest X-ray if indicated)
• Myocardial infarction (check troponin, ECG)
• Medication non-compliance or new-onset diabetes
• Pancreatitis, stroke, or other acute illness 1

The yellow-green vomitus warrants consideration of hemorrhagic gastritis (occurs in up to 25% of DKA cases) or other gastrointestinal pathology 1.